Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 1.16 ▲ 0.02 (1.75%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.01 | -0.87% | 1.14 | 1.45 | 1.12 | 1.18 | 1.15 | 19:59:26 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.16 | 1.27 | 0.11 | 8.66% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,051 | 3,020,842 | $ 1.29 | $ 3,899,154 | 604,775 | 0.40 - 1.63 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:26 | formt | 257 | $ 1.16 | USD |
Citius Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 32.98M | 28.93M | $ -12.54M | -0.78 | - | 16.62M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 12.00 | 42.70% |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.834 | 1.45 | 0.82 | 1.05 | 695,929 | 0.306 | 36.69% |
| 1 Month | 0.62 | 1.45 | 0.57 | 0.9600043 | 882,637 | 0.52 | 83.87% |
| 3 Months | 0.5885 | 1.45 | 0.40 | 0.821145 | 426,927 | 0.5515 | 93.71% |
| 6 Months | 1.02 | 1.50 | 0.40 | 0.8368751 | 276,019 | 0.12 | 11.76% |
| 1 Year | 1.15 | 1.63 | 0.40 | 0.9440786 | 214,447 | -0.01 | -0.87% |
| 3 Years | 3.40 | 5.49 | 0.40 | 1.53 | 144,000 | -2.26 | -66.47% |
| 5 Years | 3.40 | 5.49 | 0.40 | 1.53 | 144,000 | -2.26 | -66.47% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. The company is primarily operating within the critical care and cancer care market segments. |
